ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder
|
|
Fredrickdouglas
|
74 |
24K |
1 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
74
|
24K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder
|
|
Fredrickdouglas
|
74 |
24K |
4 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
74
|
24K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Fredrickdouglas
|
228 |
86K |
4 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
228
|
86K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Fredrickdouglas
|
228 |
86K |
17 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
228
|
86K
|
17
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Fredrickdouglas
|
109 |
41K |
4 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
109
|
41K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Fredrickdouglas
|
228 |
86K |
5 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
228
|
86K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
Fredrickdouglas
|
228 |
86K |
6 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
228
|
86K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Fredrickdouglas
|
109 |
41K |
10 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
109
|
41K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Fredrickdouglas
|
109 |
41K |
3 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Fredrickdouglas
|
109 |
41K |
12 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Fredrickdouglas
|
109 |
41K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
Fredrickdouglas
|
109 |
41K |
9 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
109
|
41K
|
9
|
|
Charts
|
PER |
Re:
Chart
|
|
Fredrickdouglas
|
5.9K |
2.2M |
4 |
05/08/22 |
05/08/22 |
Charts
|
5.9K
|
2.2M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Fredrickdouglas
|
31 |
7.8K |
4 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
31
|
7.8K
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
0 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Fredrickdouglas
|
5.9K |
2.2M |
4 |
22/07/22 |
22/07/22 |
Charts
|
5.9K
|
2.2M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe
|
|
Fredrickdouglas
|
93 |
24K |
4 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
93
|
24K
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
Fredrickdouglas
|
5.9K |
2.2M |
6 |
11/07/22 |
11/07/22 |
Charts
|
5.9K
|
2.2M
|
6
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
09/07/22 |
09/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
7 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
9 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long COVID-19 strategic collaboration with US Experts
|
|
Fredrickdouglas
|
245 |
70K |
3 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
245
|
70K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Fredrickdouglas
|
3.5K |
1.0M |
7 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
CR Shortfall
|
|
Fredrickdouglas
|
99 |
30K |
4 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
99
|
30K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Q4 2021 Quarterly Update and Appendix 4C
|
|
Fredrickdouglas
|
21 |
11K |
5 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
21
|
11K
|
5
|
|
ASX - By Stock
|
PER |
Re:
AGM on now
|
|
Fredrickdouglas
|
78 |
22K |
3 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
78
|
22K
|
3
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Fredrickdouglas
|
855 |
236K |
0 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
855
|
236K
|
0
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Fredrickdouglas
|
855 |
236K |
9 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
855
|
236K
|
9
|
|
Charts
|
PER |
Re:
Chart
|
|
Fredrickdouglas
|
5.9K |
2.2M |
0 |
09/11/21 |
09/11/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Fredrickdouglas
|
855 |
236K |
1 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
855
|
236K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Fredrickdouglas
|
166 |
50K |
0 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
166
|
50K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Fredrickdouglas
|
166 |
50K |
2 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
166
|
50K
|
2
|
|
ASX - By Stock
|
PER |
Re:
How long does Sarepta Gene Therapy last?
|
|
Fredrickdouglas
|
5 |
1.8K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
5
|
1.8K
|
2
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Fredrickdouglas
|
855 |
236K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
236K
|
4
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
Fredrickdouglas
|
855 |
236K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
855
|
236K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Fredrickdouglas
|
143 |
50K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
143
|
50K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
Fredrickdouglas
|
221 |
80K |
8 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
221
|
80K
|
8
|
|
Charts
|
PER |
Re:
Chart
|
|
Fredrickdouglas
|
5.9K |
2.2M |
10 |
30/08/21 |
30/08/21 |
Charts
|
5.9K
|
2.2M
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD
|
|
Fredrickdouglas
|
174 |
46K |
2 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
174
|
46K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP and MCRI new R&D collaboration for ATL1102
|
|
Fredrickdouglas
|
287 |
92K |
12 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
287
|
92K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP and MCRI new R&D collaboration for ATL1102
|
|
Fredrickdouglas
|
287 |
92K |
8 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
287
|
92K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
|
|
Fredrickdouglas
|
191 |
58K |
11 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
191
|
58K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Another Indication for Atl1102
|
|
Fredrickdouglas
|
2 |
1.5K |
4 |
15/05/21 |
15/05/21 |
ASX - By Stock
|
2
|
1.5K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Type C Meeting for ATL1102 in DMD
|
|
Fredrickdouglas
|
87 |
33K |
26 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
87
|
33K
|
26
|
|
Charts
|
PER |
Re:
Chart
|
|
Fredrickdouglas
|
5.9K |
2.2M |
3 |
19/04/21 |
19/04/21 |
Charts
|
5.9K
|
2.2M
|
3
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Fredrickdouglas
|
183 |
76K |
3 |
10/04/21 |
10/04/21 |
ASX - By Stock
|
183
|
76K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
Fredrickdouglas
|
413 |
166K |
15 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
413
|
166K
|
15
|
|